Advanced search
Publication Cover
The American Journal of Drug and Alcohol Abuse
Encompassing All Addictive Disorders
Volume 32, 2006 - Issue 4
Submit an article Journal homepage
287
Views
62
CrossRef citations to date
0
Altmetric
Original

Modafinil and Cocaine Interactions

Robert Malcolm Center for Drug and Alcohol Programs, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina (MUSC), Charleston, South Carolina, USACorrespondence[email protected]
,
Karla Swayngim Center for Drug and Alcohol Programs, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina (MUSC), Charleston, South Carolina, USA
,
Jennifer L. Donovan Laboratory of Drug Disposition and Pharmacogenetics, Department of Psychiatry and Behavioral Sciences, MUSC, Charleston, South Carolina, USA
,
C. Lindsay DeVane Laboratory of Drug Disposition and Pharmacogenetics, Department of Psychiatry and Behavioral Sciences, MUSC, Charleston, South Carolina, USA
,
Ahmed Elkashef National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland, USA
,
Nora Chiang National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland, USA
,
Roberta Khan Laboratory of Drug Disposition and Pharmacogenetics, Department of Psychiatry and Behavioral Sciences, MUSC, Charleston, South Carolina, USA
,
Jurij Mojsiak National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland, USA
,
Donald L. Myrick Center for Drug and Alcohol Programs, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina (MUSC), Charleston, South Carolina, USA
,
Sarra Hedden Department of Biostatistics, Bioinformatics and Epidemiology, MUSC, Charleston, South Carolina, USA
,
Kristi Cochran Center for Drug and Alcohol Programs, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina (MUSC), Charleston, South Carolina, USA
&
Robert F. Woolson Department of Biostatistics, Bioinformatics and Epidemiology, MUSC, Charleston, South Carolina, USA
 show all
Pages 577-587 | Published online: 07 Jul 2009

Citations (62)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Dinesh Sangroula, Fatima Motiwala, Bivek Wagle, Vivek C. Shah, Katsuhiko Hagi & Steven Lippmann. (2017) Modafinil Treatment of Cocaine Dependence: A Systematic Review and Meta-Analysis. Substance Use & Misuse 52:10, pages 1292-1306.
Read now
Jee Hyun Kim & Andrew J Lawrence. (2014) Drugs currently in Phase II clinical trials for cocaine addiction. Expert Opinion on Investigational Drugs 23:8, pages 1105-1122.
Read now
Gabriel C Quintero. (2013) Role of nucleus accumbens glutamatergic plasticity in drug addiction. Neuropsychiatric Disease and Treatment 9, pages 1499-1512.
Read now
Christopher D Verrico, Colin N Haile, Thomas F Newton, Thomas R Kosten & Richard De La Garza. (2013) Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications. Expert Opinion on Investigational Drugs 22:12, pages 1549-1568.
Read now
Noèlia Fernàndez-castillo, Bru Cormand, Carlos Roncero, Cristina Sánchez-Mora, Lara Grau-Lopez, Begoña Gonzalvo, Laia Miquel, Roser Corominas, Josep Antoni Ramos-Quiroga, Miquel Casas & Marta Ribasés. (2012) Candidate pathway association study in cocaine dependence: The control of neurotransmitter release. The World Journal of Biological Psychiatry 13:2, pages 126-134.
Read now
James Shearer. (2008) The principles of agonist pharmacotherapy for psychostimulant dependence. Drug and Alcohol Review 27:3, pages 301-308.
Read now

Articles from other publishers (56)

Melinda Hersey & Gianluigi Tanda. 2023.
Michelle A. Carroll Turpin, Kevin Rowland, Charles Anugwom, Marina Arocha, Anthony Carona, Brianna I. Gonzalez, Geina Iskander, Sarah Snyder, Kennedi Wilson, Alan David Kaye & Elyse M. Cornett. 2023. Substance Use and Addiction Research. Substance Use and Addiction Research 233 263 .
Quang Ngo & David T. Plante. (2022) An Update on the Misuse and Abuse Potential of Pharmacological Treatments for Central Disorders of Hypersomnolence. Current Sleep Medicine Reports 8:4, pages 147-159.
Crossref
Samantha N Scott, Raul Garcia, Gregory L Powell, Sophia M Doyle, Brielle Ruscitti, Tien Le, Aracely Esquer, Kevin M Blattner, Benjamin E Blass & Janet L Neisewander. (2021) 5-HT 1B receptor agonist attenuates cocaine self-administration after protracted abstinence and relapse in rats . Journal of Psychopharmacology 35:10, pages 1216-1225.
Crossref
Laura Brandt, Thomas Chao, Sandra D. Comer & Frances R. Levin. (2020) Pharmacotherapeutic strategies for treating cocaine use disorder—what do we have to offer?. Addiction 116:4, pages 694-710.
Crossref
Margaret Haney, Eric Rubin, Rebecca K. Denson & Richard W. Foltin. (2021) Modafinil reduces smoked cocaine self-administration in humans: effects vary as a function of cocaine ‘priming’ and cost. Drug and Alcohol Dependence 221, pages 108554.
Crossref
Adriano Zager. (2020) Modulating the immune response with the wake-promoting drug modafinil: A potential therapeutic approach for inflammatory disorders. Brain, Behavior, and Immunity 88, pages 878-886.
Crossref
Kyle M. Kampman. (2019) The treatment of cocaine use disorder. Science Advances 5:10.
Crossref
Joy M. Schmitz, Angela L. Stotts, Anka A. Vujanovic, Michael F. Weaver, Jin H. Yoon, Jessica Vincent & Charles E. Green. (2018) A sequential multiple assignment randomized trial for cocaine cessation and relapse prevention: Tailoring treatment to the individual. Contemporary Clinical Trials 65, pages 109-115.
Crossref
Hai-Ying Zhang, Guo-Hua Bi, Hong-Ju Yang, Yi He, Gilbert Xue, Jiajing Cao, Gianluigi Tanda, Eliot L Gardner, Amy Hauck Newman & Zheng-Xiong Xi. (2017) The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic. Neuropsychopharmacology 42:9, pages 1871-1883.
Crossref
Geraldine Dowling, Pierce V. Kavanagh, Brian Talbot, John O’Brien, Gary Hessman, Gavin McLaughlin, Brendan Twamley & Simon D. Brandt. (2017) Outsmarted by nootropics? An investigation into the thermal degradation of modafinil, modafinic acid, adrafinil, CRL-40,940 and CRL-40,941 in the GC injector: formation of 1,1,2,2-tetraphenylethane and its tetra fluoro analog. Drug Testing and Analysis 9:3, pages 518-528.
Crossref
Jianjing Cao, Rachel D. Slack, Oluyomi M. Bakare, Caitlin Burzynski, Rana Rais, Barbara S. Slusher, Theresa Kopajtic, Alessandro Bonifazi, Michael P. Ellenberger, Hideaki Yano, Yi He, Guo-Hua Bi, Zheng-Xiong Xi, Claus J. Loland & Amy Hauck Newman. (2016) Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors. Journal of Medicinal Chemistry 59:23, pages 10676-10691.
Crossref
Ariadna Amador, Salvador Huitron-Resendiz, Amanda J. Roberts, Theodore M. Kamenecka, Laura A. Solt & Thomas P. Burris. (2016) Pharmacological Targeting the REV-ERBs in Sleep/Wake Regulation. PLOS ONE 11:9, pages e0162452.
Crossref
Laurence Lalanne, Pierre-Eric Lutz, Benoit Trojak, Jean-Philippe Lang, Brigitte L. Kieffer & Elisabeth Bacon. (2016) Medications between psychiatric and addictive disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 65, pages 215-223.
Crossref
Amanda J. Quisenberry & Lisa E. Baker. (2015) Dopaminergic mediation of the discriminative stimulus functions of modafinil in rats. Psychopharmacology 232:24, pages 4411-4419.
Crossref
Kyle M. Kampman, Kevin G. Lynch, Helen M. Pettinati, Kelly Spratt, Michael R. Wierzbicki, Charles Dackis & Charles P. O’Brien. (2015) A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence. Drug and Alcohol Dependence 155, pages 105-110.
Crossref
Mascha Nuijten, Peter Blanken, Wim van den Brink & Vincent Hendriks. (2015) Modafinil in the treatment of crack-cocaine dependence in the Netherlands: Results of an open-label randomised controlled feasibility trial. Journal of Psychopharmacology 29:6, pages 678-687.
Crossref
Xiao-Fei Wang, Guo-Hua Bi, Yi He, Hong-Ju Yang, Jun-Tao Gao, Oluyomi M Okunola-Bakare, Rachel D Slack, Eliot L Gardner, Zheng-Xiong Xi & Amy Hauck Newman. (2015) R-Modafinil Attenuates Nicotine-Taking and Nicotine-Seeking Behavior in Alcohol-Preferring Rats. Neuropsychopharmacology 40:7, pages 1762-1771.
Crossref
Kevin A. Sevarino & Bryan C. Shelby. 2015. Psychiatry. Psychiatry 1561 1614 .
Maarten E.A. Reith, Bruce E. Blough, Weimin C. Hong, Kymry T. Jones, Kyle C. Schmitt, Michael H. Baumann, John S. Partilla, Richard B. Rothman & Jonathan L. Katz. (2015) Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter. Drug and Alcohol Dependence 147, pages 1-19.
Crossref
Christopher D. Verrico, Colin N. Haile, James J. Mahoney III, Daisy G.Y. Thompson-Lake, Thomas F. Newton & Richard De La Garza II. (2014) Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: A randomized, double blind, placebo-controlled human laboratory study. Drug and Alcohol Dependence 141, pages 72-78.
Crossref
Joy M. Schmitz, Charles E. Green, Angela L. Stotts, Jan A. Lindsay, Nuvan S. Rathnayaka, John Grabowski & F. Gerard Moeller. (2014) A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: Modafinil, levodopa–carbidopa, naltrexone. Drug and Alcohol Dependence 136, pages 100-107.
Crossref
Maddalena Mereu, Antonello Bonci, Amy Hauck Newman & Gianluigi Tanda. (2013) The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders. Psychopharmacology 229:3, pages 415-434.
Crossref
Amanda J. Quisenberry, Thomas Prisinzano & Lisa E. Baker. (2013) Combined effects of modafinil and d-amphetamine in male Sprague–Dawley rats trained to discriminate d-amphetamine. Pharmacology Biochemistry and Behavior 110, pages 208-215.
Crossref
Charles A. Dackis, Kyle M. Kampman, Kevin G. Lynch, Jennifer G. Plebani, Helen M. Pettinati, Thorne Sparkman & Charles P. O'Brien. (2012) A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Journal of Substance Abuse Treatment 43:3, pages 303-312.
Crossref
Charles P. O'Brien. (2012) Modafinil-Cocaine Interactions: Clinical Implications. Biological Psychiatry 72:5, pages 346.
Crossref
Colin N. Haile, James J. MahoneyIIIIII, Thomas F. Newton & Richard De La GarzaIIII. (2012) Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: Focus on dopamine, norepinephrine and glutamate. Pharmacology & Therapeutics 134:2, pages 260-277.
Crossref
Craig R RushWilliam W Stoops. (2012) Agonist replacement therapy for cocaine dependence: a translational review. Future Medicinal Chemistry 4:2, pages 245-265.
Crossref
M. Foster Olive, Richard M. Cleva, Peter W. Kalivas & Robert J. Malcolm. (2012) Glutamatergic medications for the treatment of drug and behavioral addictions. Pharmacology Biochemistry and Behavior 100:4, pages 801-810.
Crossref
Christine Yuodelis-Flores, Richard K. Ries & W. Murray Bennett. 2012. Handbook of Community Psychiatry. Handbook of Community Psychiatry 277 292 .
Kathleen T. Brady, Kevin M. Gray & Bryan K. Tolliver. (2011) Cognitive enhancers in the treatment of substance use disorders: Clinical evidence. Pharmacology Biochemistry and Behavior 99:2, pages 285-294.
Crossref
Dawn E. Sugarman, James Poling & Mehmet Sofuoglu. (2011) The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans. Pharmacology Biochemistry and Behavior 98:1, pages 94-100.
Crossref
Clara Pérez-Mañá, Xavier Castells, Xavier Vidal, Miguel Casas & Dolors Capellà. (2011) Efficacy of indirect dopamine agonists for psychostimulant dependence: A systematic review and meta-analysis of randomized controlled trials. Journal of Substance Abuse Treatment 40:2, pages 109-122.
Crossref
Joachim D. Uys & Kathryn J. Reissner. 2011. The Brain as a Drug Target. The Brain as a Drug Target 367 400 .
Pouya Tahsili-Fahadan, Gregory V Carr, Glenda C Harris & Gary Aston-Jones. (2010) Modafinil Blocks Reinstatement of Extinguished Opiate-Seeking in Rats: Mediation by a Glutamate Mechanism. Neuropsychopharmacology 35:11, pages 2203-2210.
Crossref
Kyle M. Kampman. (2010) What’s New in the Treatment of Cocaine Addiction?. Current Psychiatry Reports 12:5, pages 441-447.
Crossref
David V. Herin, Craig. R. Rush & John Grabowski. (2010) Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies. Annals of the New York Academy of Sciences 1187:1, pages 76-100.
Crossref
Heath D. Schmidt & R. Christopher Pierce. (2010) Cocaine-induced neuroadaptations in glutamate transmission. Annals of the New York Academy of Sciences 1187:1, pages 35-75.
Crossref
Bianca Jupp & Andrew J. Lawrence. (2010) New horizons for therapeutics in drug and alcohol abuse. Pharmacology & Therapeutics 125:1, pages 138-168.
Crossref
Suzanne K. Vosburg, Carl L. Hart, Margaret Haney, Eric Rubin & Richard W. Foltin. (2010) Modafinil does not serve as a reinforcer in cocaine abusers. Drug and Alcohol Dependence 106:2-3, pages 233-236.
Crossref
Ellen Edens, Alfredo Massa & Ismene Petrakis. 2010. Behavioral Neuroscience of Drug Addiction. Behavioral Neuroscience of Drug Addiction 343 386 .
Noushin Yahyavi-Firouz-Abadi & Ronald E. See. (2009) Anti-relapse medications: Preclinical models for drug addiction treatment. Pharmacology & Therapeutics 124:2, pages 235-247.
Crossref
Dorota Zolkowska, Raka Jain, Richard B. Rothman, John S. Partilla, Bryan L. Roth, Vincent Setola, Thomas E. Prisinzano & Michael H. Baumann. (2009) Evidence for the Involvement of Dopamine Transporters in Behavioral Stimulant Effects of Modafinil. Journal of Pharmacology and Experimental Therapeutics 329:2, pages 738-746.
Crossref
James Shearer, Shane Darke, Craig Rodgers, Tim Slade, Ingrid Van Beek, John Lewis, Donna Brady, Rebecca McKetin, Richard P. Mattick & Alex Wodak. (2009) A double‐blind, placebo‐controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction 104:2, pages 224-233.
Crossref
L. Karila, G. Lafaye & M. Reynaud. (2009) L'addiction à la cocaïne : de l'épidémiologie aux approches thérapeutiques. L'information psychiatrique 85:7, pages 647.
Crossref
Margaret Haney. (2009) Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls. Addiction Biology 14:1, pages 9-21.
Crossref
Charles P. O'Brien, A. Thomas McLellan, Anna Rose Childress & George E. Woody. (2009) Penn/VA center for studies of addiction. Neuropharmacology 56, pages 44-47.
Crossref
Charles P O'Brien. (2008) Evidence-based treatments of addiction. Philosophical Transactions of the Royal Society B: Biological Sciences 363:1507, pages 3277-3286.
Crossref
Margaret Haney & Roger Spealman. (2008) Controversies in translational research: drug self-administration. Psychopharmacology 199:3, pages 403-419.
Crossref
Michael J Minzenberg & Cameron S Carter. (2007) Modafinil: A Review of Neurochemical Actions and Effects on Cognition. Neuropsychopharmacology 33:7, pages 1477-1502.
Crossref
Laurent Karila, David Gorelick, Aviv Weinstein, Florence Noble, Amine Benyamina, Sarah Coscas, Lisa Blecha, William Lowenstein, Jean Luc Martinot, Michel Reynaud & Jean Pierre Lépine. (2007) New treatments for cocaine dependence: a focused review. The International Journal of Neuropsychopharmacology 11:03.
Crossref
Carl L Hart, Margaret Haney, Suzanne K Vosburg, Eric Rubin & Richard W Foltin. (2007) Smoked Cocaine Self-Administration is Decreased by Modafinil. Neuropsychopharmacology 33:4, pages 761-768.
Crossref
Peter W Kalivas & Charles O'Brien. (2007) Drug Addiction as a Pathology of Staged Neuroplasticity. Neuropsychopharmacology 33:1, pages 166-180.
Crossref
Justin T. Gass & M. Foster Olive. (2008) Glutamatergic substrates of drug addiction and alcoholism. Biochemical Pharmacology 75:1, pages 218-265.
Crossref
Beatriz A. Rocha, Jack Bergman, Sandra D. Comer, Margaret Haney & Roger D. Spealman. 2008. Animal and Translational Models for CNS Drug Discovery. Animal and Translational Models for CNS Drug Discovery 221 270 .
Mehmet Sofuoglu, Andrew J. Waters & Marc Mooney. (2007) Modafinil and nicotine interactions in abstinent smokers. Human Psychopharmacology: Clinical and Experimental 23:1, pages 21-30.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.